Read + Share
Amedeo Smart
Independent Medical Education
Yang Z, Liu C, Hu Y, Liu H, et al. Tyrosine kinase inhibitors combined with venetoclax and azacytidine as an effective therapy for de novo lymphoid blast phase-chronic myeloid leukemia. Leuk Res 2023;127:107039.PMID: 36812660
Email
LinkedIn
Facebook
Twitter
Privacy Policy